-
公开(公告)号:US20080287374A1
公开(公告)日:2008-11-20
申请号:US12181957
申请日:2008-07-29
申请人: Ryuta YAMAZAKI , Yukiko Nishiyama , Tomio Furuta , Takeshi Matsuzaki , Hiroshi Hatano , Sachiko Matsumoto , Ritsuo Aiyama , Oh Yoshida , Masato Nagaoka , Shusuke Hashimoto , Yoshikazu Sugimoto
发明人: Ryuta YAMAZAKI , Yukiko Nishiyama , Tomio Furuta , Takeshi Matsuzaki , Hiroshi Hatano , Sachiko Matsumoto , Ritsuo Aiyama , Oh Yoshida , Masato Nagaoka , Shusuke Hashimoto , Yoshikazu Sugimoto
IPC分类号: A61K31/352 , A61K31/7048 , A61P35/00
CPC分类号: G01N33/57415 , A61K31/121 , A61K31/352 , C07D311/30 , C07D493/04 , G01N33/5011
摘要: The invention provides a cancer cell useful in screening BCRP-inhibitors, and a BCRP-inhibitor.The BCRP-inhibitor contains, as the active ingredient, a flavonoid represented by any of the following formulae (1), (2), (3), (4), and (5): and glycosides, esters, or salts thereof; and an anticancer agent containing the BCRP-inhibitor together with an anticancer agent available as the substrate of BCRP.
摘要翻译: 本发明提供了可用于筛选BCRP抑制剂和BCRP抑制剂的癌细胞。 BCRP抑制剂含有下列通式(1),(2),(3),(4)和(5)中任一项所示的类黄酮作为活性成分:及其糖苷,酯或其盐; 以及含有BCRP抑制剂的抗癌剂和可用作BCRP底物的抗癌剂。
-
公开(公告)号:US07371773B2
公开(公告)日:2008-05-13
申请号:US10544064
申请日:2004-02-03
申请人: Ryuta Yamazaki , Yukiko Nishiyama , Tomio Furuta , Takeshi Matsuzaki , Hiroshi Hatano , Oh Yoshida , Masato Nagaoka , Ritsuo Aiyama , Shusuke Hashimoto , Yoshikazu Sugimoto
发明人: Ryuta Yamazaki , Yukiko Nishiyama , Tomio Furuta , Takeshi Matsuzaki , Hiroshi Hatano , Oh Yoshida , Masato Nagaoka , Ritsuo Aiyama , Shusuke Hashimoto , Yoshikazu Sugimoto
IPC分类号: A61K31/415
CPC分类号: C07D211/58 , A61K31/277 , A61K31/7034 , C07C255/37 , C07D317/60
摘要: The invention provides a drug which inhibits BCRP.A breast cancer resistance protein inhibitor containing, as an active ingredient, a diphenylacrylonitrile derivative represented by the following formula (1): [wherein, each of 8 R's, which are the same or different from one another, represents a hydrogen atom, a hydroxyl group, a nitro group, an amino group, an acetylamino group (—NHCOCH3 group); a cyano group (—CN group); a formyl group (—CHO group), —COOR1 (R1 is hydrogen or C1-C4 alkyl), —O(CH2)nCOOR2 (n=1−7: R2 is hydrogen or C1-C4 alkyl), —OOCCH2CH2COOR3 (R3 is hydrogen, C1-C4 alkyl, (Z)-2-(3,4-dimethoxy-phenyl)-3-(4-hydroxy-phenyl)-acrylonitrile, or glycopyranosyl), a C1-C8 alkoxy group, a C1-C4 alkyl group, a halogen atom, a C1-C4 alkoxy C1-C4 alkoxy C1-C4 alkoxy group, a C2-C8 acyloxy group, a C2-C8 halogenoacyloxy group, a methylenedioxy group, a trifluoromethyl group, a phosphate group (i.e., —OP(O) (OH)2) or a salt thereof, a sulfate group (i.e., —OSO3H) or a salt thereof, a glycopyranosyl group or a salt thereof, a phosphate ester of a glycopyranosyl group or a salt of the ester, a sulfate ester of a glycopyranosyl group or a salt of the ester, or a piperidinopiperidinocarbonyloxy group], an ester thereof, or a salt thereof.
摘要翻译: 本发明提供抑制BCRP的药物。 作为活性成分,含有下述式(1)表示的二苯基丙烯腈衍生物的乳
球癌抗性蛋白质抑制剂:[其中,8个相同或不同的8个R代表氢原子,羟基 基团,硝基,氨基,乙酰氨基(-NHCOCH 3 SO 3); 氰基(-CN基); 甲酰基(-CHO基),-COOR 1(R 1是氢或C 1 -C 4烷基),-O(CH 2) )nOR 2(n = 1-7:R 2是氢或C 1 -C 4烷基),-OOCCH 2 (R 3)是氢,C 1 -C 4烷基,(Z)-2-(3,4-二氯苯基) 二甲氧基 - 苯基)-3-(4-羟基 - 苯基) - 丙烯腈或糖吡喃糖基),C1-C8烷氧基,C1-C4烷基,卤素原子,C1-C4烷氧基C1-C4烷氧基C1- C4烷氧基,C2-C8酰氧基,C2-C8卤代酰氧基,亚甲二氧基,三氟甲基,磷酸基(即-OP(O)(OH)2))或 其盐,硫酸基(即-OSO 3 H)或其盐,糖吡喃糖基或其盐,糖吡喃糖基的磷酸酯或酯的盐, 糖吡喃糖基的硫酸酯或酯的盐或哌啶子基哌啶羰基氧基],其酯或其盐。-
公开(公告)号:US06645940B2
公开(公告)日:2003-11-11
申请号:US10313466
申请日:2002-12-06
IPC分类号: A61K3170
CPC分类号: C07H15/04
摘要: An oligosaccharide derivative, at higher homogeneity than fucose polysaccharide and rhamnose polysaccharide and with greater antiulcer effects, which is represented by the following general formula: Y—OCH(CH2NHR)2 wherein, Y represents an oligofucose or oligorhamnose at a polymerization number of 2 to 20, where the hydroxyl groups may or may not be partially modified in the form of sulfate ester, and R represents phenyl group, a higher alkylphenyl group, a higher alkyl group or —(CH2)n—NHX wherein n is an integer of 1 to 10 and X represents a higher alkanoyl group or an alkylamino group.
-
公开(公告)号:US06518249B1
公开(公告)日:2003-02-11
申请号:US09485978
申请日:2000-02-18
IPC分类号: A61K3170
CPC分类号: C07H15/04
摘要: An oligosaccharide derivative, at higher homogeneity than fucose polysaccharide and rhamnose polysaccharide and with greater antiulcer effects, which is represented by the following general formula: Y—OCH(CH2NHR)2 wherein, Y represents an oligofucose or oligorhamnose at a polymerization number of 2 to 20, where the hydroxyl groups may or may not be partially modified in the form of sulfate ester, and R represents phenyl group, a higher alkylphenyl group, a higher alkyl group or —(CH2)n—NHX wherein n is an integer of 1 to 10 and X represents a higher alkanoyl group or an alkylamino group.
摘要翻译: 一种低聚糖衍生物,其比岩藻糖多糖和鼠李糖多糖具有更高的均一性,并且具有较大的抗溃疡作用,其由以下通式表示:其中Y表示聚合数为2至20的寡聚核糖或寡鼠李糖,其中羟基可以 或可以不以硫酸酯的形式部分修饰,R代表苯基,高级烷基苯基,高级烷基或 - (CH2)n-NHX,其中n为1至10的整数,X表示较高的 烷酰基或烷基氨基。
-
-
-